These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 23726880

  • 1. Involvement of chymase in allergic conjunctivitis of guinea pigs.
    Nabe T, Kijitani Y, Kitagawa Y, Sakano E, Ueno T, Fujii M, Nakao S, Sakai M, Takai S.
    Exp Eye Res; 2013 Aug; 113():74-9. PubMed ID: 23726880
    [Abstract] [Full Text] [Related]

  • 2. Multiple cedar pollen challenge diminishes involvement of histamine in allergic conjunctivitis of Guinea pigs.
    Fukushima Y, Nabe T, Mizutani N, Nakata K, Kohno S.
    Biol Pharm Bull; 2003 Dec; 26(12):1696-700. PubMed ID: 14646173
    [Abstract] [Full Text] [Related]

  • 3. Effects of multiple dexamethasone treatments on aggravation of allergic conjunctivitis associated with mast cell hyperplasia.
    Nagata T, Nabe T, Fujii M, Mizutani N, Kohno S.
    Biol Pharm Bull; 2008 Mar; 31(3):464-8. PubMed ID: 18310911
    [Abstract] [Full Text] [Related]

  • 4. The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent.
    Yanni JM, Stephens DJ, Miller ST, Weimer LK, Graff G, Parnell D, Lang LS, Spellman JM, Brady MT, Gamache DA.
    J Ocul Pharmacol Ther; 1996 Mar; 12(4):389-400. PubMed ID: 8951675
    [Abstract] [Full Text] [Related]

  • 5. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
    Kida T, Fujii A, Sakai O, Iemura M, Atsumi I, Wada T, Sakaki H.
    Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
    [Abstract] [Full Text] [Related]

  • 6. An experimental allergic conjunctivitis induced by topical and repetitive applications of Japanese cedar pollens in guinea pigs.
    Yasuda M, Kato M, Nabe T, Nakata K, Kohno S.
    Inflamm Res; 1999 Jun; 48(6):325-36. PubMed ID: 10442485
    [Abstract] [Full Text] [Related]

  • 7. Experimental allergic conjunctivitis in guinea pigs induced by Japanese cedar pollen.
    Takada M, Yamada T, Nakahara H, Sugimoto Y, Izushi K, Kamei C.
    Biol Pharm Bull; 2000 May; 23(5):566-9. PubMed ID: 10823665
    [Abstract] [Full Text] [Related]

  • 8. Mast cell hyperplasia induced by multiple challenge with cedar pollen in sensitised guinea pigs.
    Katayama G, Nabe T, Fujii M, Kohno S.
    Inflamm Res; 2005 Sep; 54(9):370-4. PubMed ID: 16273335
    [Abstract] [Full Text] [Related]

  • 9. Effect of antihistamine eye drops on the conjunctival provocation test with Japanese cedar pollen allergen.
    Dake Y, Enomoto T, Cheng L, Enomoto K, Shibano A, Ikeda H, Yoda S, Yajin S, Sakota T, Yamanishi E.
    Allergol Int; 2006 Dec; 55(4):373-8. PubMed ID: 17130679
    [Abstract] [Full Text] [Related]

  • 10. Experimental model of allergic conjunctivitis to ragweed in guinea pig.
    Merayo-Lloves J, Calonge M, Foster CS.
    Curr Eye Res; 1995 Jun; 14(6):487-94. PubMed ID: 7671631
    [Abstract] [Full Text] [Related]

  • 11. Ocular anti-allergic compounds selectively inhibit human mast cell cytokines in vitro and conjunctival cell infiltration in vivo.
    Galatowicz G, Ajayi Y, Stern ME, Calder VL.
    Clin Exp Allergy; 2007 Nov; 37(11):1648-56. PubMed ID: 17877767
    [Abstract] [Full Text] [Related]

  • 12. A current appreciation of sites for pharmacological intervention in allergic conjunctivitis: effects of new topical ocular drugs.
    Yanni JM, Sharif NA, Gamache DA, Miller ST, Weimer LK, Spellman JM.
    Acta Ophthalmol Scand Suppl; 1999 Nov; (228):33-7. PubMed ID: 10337430
    [Abstract] [Full Text] [Related]

  • 13. Cyclosporine A eye drops inhibit the early-phase reaction in a type-I allergic conjunctivitis model in mice.
    Shii D, Oda T, Shinomiya K, Katsuta O, Nakamura M.
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):321-8. PubMed ID: 19650707
    [Abstract] [Full Text] [Related]

  • 14. Involvement of leukotriene B4 in itching in a mouse model of ocular allergy.
    Andoh T, Sakai K, Urashima M, Kitazawa K, Honma A, Kuraishi Y.
    Exp Eye Res; 2012 May; 98():97-103. PubMed ID: 22504036
    [Abstract] [Full Text] [Related]

  • 15. The role of platelet activating factor and the efficacy of apafant ophthalmic solution in experimental allergic conjunctivitis.
    Kato M, Kurose T, Oda T, Miyaji S.
    J Ocul Pharmacol Ther; 2003 Aug; 19(4):315-24. PubMed ID: 12964956
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Effect of fenitrothion on experimental allergic conjunctivitis].
    Nakamura Y, Kato H, Kishida F, Kogiso S, Nakatsuka I.
    J Toxicol Sci; 1996 Nov; 21 Suppl 3():485-93. PubMed ID: 9021657
    [Abstract] [Full Text] [Related]

  • 18. Effects of nonsteroidal anti-inflammatory drugs on experimental allergic conjunctivitis in Guinea pigs.
    Hashimoto T, Igarashi A, Hoshina F, Yamada M, Toyoda Y, Notsu Y, Kohno S.
    J Ocul Pharmacol Ther; 2003 Dec; 19(6):569-77. PubMed ID: 14733714
    [Abstract] [Full Text] [Related]

  • 19. The effect of topically applied secretory leukocyte protease inhibitor on the eosinophil response in the late phase of allergic conjunctivitis.
    Murata E, Sharmin S, Shiota H, Shiota M, Yano M, Kido H.
    Curr Eye Res; 2003 May; 26(5):271-6. PubMed ID: 12854054
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.